The lab's interest includes antibiotic resistance, systems biology, and microbial experimental evolution. Account run by lab members. @csabapallab.bsky.social
🚨 Our latest research in @NatureComms shows a promising strategy for less resistance-prone #antibiotics. For details, see the thread below and read the paper “Exploring the principles behind antibiotics with limited resistance” here: nature.com/articles/s41467-0…
🎓 Warm congrats to Elvin Maharramov @Ely_win on a successful PhD defense on the principles of designing #antibiotics with limited #resistance. A timely and elegant contribution to the field of #DrugDevelopment on how to design less resistance-prone antibiotics. More info below👇
Target type is critical: antibiotics that disrupt membrane integrity while blocking a second essential pathway show markedly reduced resistance evolution in #GramNegative pathogens. #AMR
🚨 Our latest research in @NatureComms shows a promising strategy for less resistance-prone #antibiotics. For details, see the thread below and read the paper “Exploring the principles behind antibiotics with limited resistance” here: nature.com/articles/s41467-0…
Excited to share our collaborative work led by the Szilvia Juhasz and Mate Manczinger @matemanc labs: #cancer mutations converge into five protein-level “fingerprints” that shape tumor immune visibility. Mutation burden alone fails to predict #immunotherapy response! @MolSystBiol
🚨 Our latest research in @NatureComms shows a promising strategy for less resistance-prone #antibiotics. For details, see the thread below and read the paper “Exploring the principles behind antibiotics with limited resistance” here: nature.com/articles/s41467-0…
Excited to share a new collaboration with the @Csaba_Pal_Lab, out now in @NatureMicrobiol!
The study highlights how ESKAPE pathogens adapt to emerging antibiotics:
🚨 Excited to share that our new study, “ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro” is just published in @NatureMicrobiol. For details, see the 🧵below and read the paper here: nature.com/articles/s41564-0…
ESKAPE pathogens are outsmarting us. Our latest paper in @NatureMicrobiol reveals alarming ease of resistance evolution to antibiotics in development. Collaborative work with @Csaba_Pal_Lab and @KintsesLab
🚨 Excited to share that our new study, “ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro” is just published in @NatureMicrobiol. For details, see the 🧵below and read the paper here: nature.com/articles/s41564-0…
The common bacterial pathogen #Saureus quickly evolves resistance to a range of experimental and recently approved #antibiotics, according to a new systems analysis that could inform future drug development efforts. @Csaba_Pal_Lab@SysbioSscim.ag/4gQmPBp
🚨 Excited to share that our new study, “ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro” is just published in @NatureMicrobiol. For details, see the 🧵below and read the paper here: nature.com/articles/s41564-0…
Thrilled to share our latest work, "Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance" in @ScienceTM! For details, see the thread below and read the paper here: science.org/doi/10.1126/scit…